A detailed history of Credit Agricole S A transactions in Dexcom Inc stock. As of the latest transaction made, Credit Agricole S A holds 158,645 shares of DXCM stock, worth $10.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
158,645
Previous 39,852 298.09%
Holding current value
$10.8 Million
Previous $5.53 Million 225.44%
% of portfolio
0.1%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $13.1 Million - $16.7 Million
118,793 Added 298.09%
158,645 $18 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $2.41 Million - $2.95 Million
21,069 Added 112.17%
39,852 $5.53 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $1.06 Million - $1.74 Million
14,042 Added 296.18%
18,783 $2.33 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $443,811 - $711,305
-5,157 Reduced 52.1%
4,741 $442,000
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $66,144 - $78,177
636 Added 6.87%
9,898 $1.15 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $19,460 - $28,091
229 Added 2.54%
9,262 $1.05 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $2.34 Million - $2.89 Million
-30,703 Reduced 77.27%
9,033 $727,000
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $2.54 Million - $4.96 Million
37,292 Added 1525.86%
39,736 $2.96 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $82,225 - $113,794
874 Added 55.67%
2,444 $1.25 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $203,895 - $255,627
1,570 New
1,570 $843,000
Q4 2017

Feb 13, 2018

SELL
$11.12 - $15.38 $158,293 - $218,934
-14,235 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $49,200 - $82,202
4,331 Added 43.73%
14,235 $697,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,904
9,904 $724,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.